|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
|
|---|---|---|---|---|---|---|---|
| Deferred offering costs | |||||||
| Current assets | |||||||
| Cash | |||||||
| Prepaid expenses | |||||||
| Total current assets | |||||||
| Deferred offering costs | |||||||
| Prepaid insurance | |||||||
| Demand deposit held in Trust Account | |||||||
| TOTAL ASSETS | |||||||
| Current liabilities | |||||||
| Accrued expenses | |||||||
| Accrued offering costs | |||||||
| Due to related party | |||||||
| Promissory note – related party | |||||||
| Related Party | |||||||
| Total promissory note – related party | |||||||
| PIPE subscription derivative liability | |||||||
| Total current liabilities | |||||||
| Deferred underwriting fee payable | |||||||
| TOTAL LIABILITIES | |||||||
| Ordinary shares subject to possible redemption, 23,000,000 shares at redemption value of $10.62 and $10.43 per share as of June 30, 2026 and December 31, 2025, respectively | |||||||
| SHAREHOLDERS’ DEFICIT | |||||||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | |||||||
| Ordinary shares, $0.0001 par value; 400,000,000 shares authorized; 6,590,000 shares issued and outstanding (excluding 23,000,000 shares subject to possible redemption) as of June 30, 2026 and December 31, 2025 | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| TOTAL SHAREHOLDERS’ DEFICIT | |||||||
| TOTAL LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT |
Loading...